You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FK506

Showing 1 - 25 of 362
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)

Completed
  • Graft Versus Host Disease in Eye
  • Beijing, Beijing, China
    Peking University Third Hospital
Mar 14, 2022

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Kidney Transplant Trial in China (Tacrolimus immediate-release formulation, Tacrolimus prolonged-release formulation, Induction

Completed
  • Kidney Transplant
  • Tacrolimus immediate-release formulation
  • +4 more
  • Beijing, China
  • +13 more
Aug 3, 2022

Posner Schlossman Syndrome Trial in Beijing (FK-506 (Drug), Prednisolone Acetate 1% Oph Susp)

Recruiting
  • Posner Schlossman Syndrome
  • FK-506 (Drug)
  • Prednisolone Acetate 1% Oph Susp
  • Beijing, Beijing, China
    Peking University Third Hosipital
Aug 13, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Biospecimen Collection
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2023

Kidney Transplant Trial in Canada, United States (Sirolimus, Belatacept, Mycophenolate Mofetil)

Not yet recruiting
  • Kidney Transplant
  • Birmingham, Alabama
  • +17 more
Sep 20, 2023

Renal Transplant Recipients Trial in China (Tacrolimus sustained-release capsule)

Completed
  • Renal Transplant Recipients
  • Tacrolimus sustained-release capsule
  • Beijing, China
  • +8 more
Jul 26, 2022

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Kidney Transplant, Delayed Graft Function Trial in Baltimore (Tacrolimus, Sirolimus)

Terminated
Has Results
  • Kidney Transplant
  • Delayed Graft Function
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 29, 2022

MCNS, Minimal Change Nephrotic Syndrome (MCNS) Trial in Seoul (Tacrolimus, Prednisolone)

Completed
  • MCNS
  • Minimal Change Nephrotic Syndrome (MCNS)
  • Seoul, Korea, Republic of
    (unnamed)
Jul 26, 2022

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Poor Thymic Function, Immunodeficiency, Athymia Trial (biological, procedure, drug)

Approved for marketing
  • Poor Thymic Function
  • +5 more
  • Cultured Thymus Tissue
  • +2 more
  • (no location specified)
Mar 23, 2022

End Stage Renal Failure With Renal Transplant Trial in Chicago (Tacrolimus with MMF, Group 2: Tacrolimus with Everolimus.)

Completed
Has Results
  • End Stage Renal Failure With Renal Transplant
  • Tacrolimus with MMF
  • Group 2: Tacrolimus with Everolimus.
  • Chicago, Illinois
    Northwestern Memorial Hospital
Feb 10, 2021

Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate

Not yet recruiting
  • Lung Transplant; Complications
  • Tacrolimus Extended Release Oral Tablet [Envarsus]
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 6, 2022

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Myasthenia Gravis Trial in Beijing (Pyridostigmine, Prednisone, Tacrolimus, Pyridostigmine, Tacrolimus)

Recruiting
  • Myasthenia Gravis
  • Pyridostigmine, Prednisone, Tacrolimus
  • Pyridostigmine, Tacrolimus
  • Beijing, Beijing, China
    Yuwei Da
Feb 21, 2021

After FK506 Immunosuppressive Therapy in Liver Transplantation

Unknown status
  • Chronic Pain
  • Liver Transplantation
  • FK506
  • Tangshan, Hebei, China
    The Second Hospital of Tangshan
Sep 16, 2020

Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

Terminated
Has Results
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
Oct 18, 2022

Complete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly Trial in Durham (biological, procedure, drug)

Approved for marketing
  • Complete DiGeorge Anomaly
  • +3 more
  • Cultured Thymus Tissue
  • +6 more
  • Durham, North Carolina
    John W. Sleasman
Mar 21, 2022

Kidney Transplantation Trial in Greenville (cyclosporine, Prograf (Tacrolimus))

Completed
Has Results
  • Kidney Transplantation
  • Greenville, North Carolina
    Brody School of Medicine at East Carolina University
Jun 9, 2021

Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,

Recruiting
  • Kidney Transplant
  • +3 more
  • Polyclonal Regulatory T Cells
  • +10 more
  • Birmingham, Alabama
  • +5 more
Feb 22, 2022

DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,

Completed
Has Results
  • DiGeorge Anomaly
  • +4 more
  • Cultured Thymus Tissue for Implantation (CTTI)
  • +8 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 23, 2022